Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sodium deoxyribonucleic acid, also known as Sodium DNA or Sodium Deoxyribonucleotide, is a sodium salt of deoxyribonucleic acid (DNA), the fundamental molecule carrying genetic instructions for all living organisms. While not officially classified as a pharmaceutical drug, it is a substance with therapeutic potential explored in medicine, biotechnology, and cosmetics. Its mechanism of action involves promoting cellular repair and regeneration by serving as a substrate for the synthesis of new DNA and RNA, thereby accelerating cellular turnover. Additionally, it is believed to modulate immune responses, reduce inflammation, promote angiogenesis (the formation of new blood vessels), and exhibit antioxidant properties by scavenging free radicals. It has been studied for its potential in wound healing, tissue regeneration, anti-aging, skin rejuvenation, hair growth, and as an adjunct in cancer therapy. It is predominantly available as a dietary supplement or a cosmetic ingredient.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium deoxyribonucleic acid.